canbas co ltd (4575:Tokyo)
canbas co ltd (4575) Snapshot
|
Open
¥2,620
|
Previous Close
¥2,670
|
|
|
Day High
¥3,140
|
Day Low
¥2,550
|
|
|
52 Week High
05/9/13 - ¥3,820
|
52 Week Low
10/11/12 - ¥365.00
|
|
|
Market Cap
10.8B
|
Average Volume 10 Days
575.3K
|
|
|
EPS TTM
¥-262.53
|
Shares Outstanding
3.6M
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
canbas co ltd (4575) Related Businessweek News
No Related Businessweek News Foundcanbas co ltd (4575) Details
CanBas Co., Ltd., a clinical stage biopharmaceutical company, engages in the discovery and development of oncology drugs in Japan. The company’s lead product is CBP501, which is in the U.S. phase II clinical trials for the treatment of late stage malignant pleural mesothelioma and non-small cell lung cancer. It also has a preclinical stage product, CBS9106. The company was founded in 2000 and is based in Numazu, Japan.
canbas co ltd (4575) Key Developments
CanBas Co., Ltd. announced that they will report Q3, 2013 results on May 14, 2013
CanBas Co., Ltd. announced that they will report Q2, 2013 results on Feb 12, 2013
CanBas Co., Ltd. announced that they will report Q1, 2013 results on Nov 12, 2012
| Recently Viewed | |||
| 4575:JP | ¥2,975.00 JPY | +305.00 | |
| Company | Last | Change | |
| No competitor information is available for 4575. | |||
| View Industry Companies | |||
Industry Analysis
4575
Industry Average
| Valuation | 4575 | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | 13.7x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | -- | Not Meaningful |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- New York, NY | New York UniversityPosted: Apr 19
Sponsored Financial Commentaries
Sponsored Links
To contact CANBAS CO LTD, please visit www.canbas.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








